Company / CapEx per Share
Travere Therapeutics, Inc. CapEx per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2023
5-year range
$0.00 / $0.01
FY2019-FY2023
Trend
+240.0%
vs FY2022
Sector context
#123 of 192
Health Care
What the data says
CapEx per Share changed +240% YoY in FY2023, a notable deviation from the 7-year average annual change of +876%.
Based on SEC 10-K filings.
0.01 in FY2023 with a 5-year CAGR of -22.1%.
Improved from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- -22.1%
- 10-Year CAGR
- -
Sector benchmark
#123 of 192 in Health CareTop 64% of 192This company $0.01 Sector average $3.54
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2023, capex per share increased 240.0% year-over-year.
- Ranks #123 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.01 | +240.0% |
| FY2022 | $0.00 | -18.1% |
| FY2021 | $0.00 | -77.9% |
| FY2020 | $0.02 | -21.3% |
| FY2019 | $0.02 | -40.9% |
| FY2018 | $0.04 | +6149.1% |
| FY2017 | $0.00 | -96.8% |
| FY2016 | $0.02 | +2052.7% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026